Effect of 5-HT4 receptor stimulation on the pacemaker current I(f) in human isolated atrial myocytes

Cardiovascular Research

Volumn 40, Issue 3, 1998, Pages 516-522

  Pino, Roberto ^a   Cerbai, Elisabetta ^a   Calamai, Giancarlo ^b   Alajmo, Franco ^b   Borgioli, Alberto ^b   Braconi, Lucio ^b   Cassai, Massimo ^b   Montesi, Gian Franco ^b   Mugelli, Alessandro ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

5 HT4 receptor subtype; Arrhythmia (mechanisms); Human atrial myocytes; Pacemaker current; Serotonin (5 HT)

Indexed keywords

SEROTONIN; SEROTONIN 4 RECEPTOR; 1 METHYL 3 INDOLECARBOXYLIC ACID [1 [2 (METHYLSULFONYLAMINO)ETHYL] 4 PIPERIDINYLMETHYL] ESTER; 2,3 DIHYDRO 2 OXO 1 BENZIMIDAZOLECARBOXYLIC ACID 6 METHOXY 3ALPHA TROPANYL ESTER; BENZIMIDAZOLE DERIVATIVE; FUSED HETEROCYCLIC RINGS; INDOLE DERIVATIVE; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR; SULFONAMIDE;

ADULT; AGED; ARRHYTHMOGENESIS; ARTICLE; CALCIUM CURRENT; CELL ISOLATION; CELL MEMBRANE POTENTIAL; CLINICAL ARTICLE; ELECTROPHYSIOLOGY; FEMALE; HEART ATRIUM PACING; HEART MUSCLE CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PACEMAKER; PATCH CLAMP; PRIORITY JOURNAL; RECEPTOR INTRINSIC ACTIVITY; ACTION POTENTIAL; DRUG EFFECT; HEART; HEART ATRIUM FIBRILLATION; MIDDLE AGED; NONPARAMETRIC TEST; PATHOPHYSIOLOGY; STIMULATION;

ACTION POTENTIALS; AGED; ATRIAL FIBRILLATION; BENZIMIDAZOLES; BICYCLO COMPOUNDS, HETEROCYCLIC; FEMALE; HEART; HUMANS; INDOLES; MALE; MIDDLE AGED; PATCH-CLAMP TECHNIQUES; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT4; SEROTONIN ANTAGONISTS; STATISTICS, NONPARAMETRIC; STIMULATION, CHEMICAL; SULFONAMIDES;

EID: 0032216690     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(98)00198-9     Document Type: Article

References (38)

1. Villalon C.M., de Vries P., Saxena P.R. Serotonin receptors as cardiovascular targets. Drug Discovery Today. 2:1997;294-300.
2. Kaumann A.J., Sanders L., Brown A.M., Murray K.J., Brown M.J. A 5-hydroxytryptamine receptor in human atrium. Br J Pharmacol. 100:1990;879-885.
3. 4-like receptors in mammalian atria. J Neural Transm. 34(suppl):1991;195-201.
4. 4 receptor cloned from human atrium. FEBS Lett. 412:1997;465-474.
5. 4-like receptor in human left atrium. Naunyn Schmiedebergs Arch Pharmacol. 345:1992;382-386.
6. Ouadid H., Seguin J., Dumuis A., Bockaert J., Nargeot J. Serotonin increases calcium current in human atrial myocytes via the newly described 5-hydroxytryptamine-4 receptors. Mol Pharmacol. 41:1992;346-351.
7. Jahnel U., Rupp J., Ertl R., Nawrath H. Positive inotropic response to 5-HT in human atrial but not in ventricular heart muscle. Naunyn Schmiedebergs Arch Pharmacol. 346:1992;482-485.
8. 4 receptors mediate arrhythmias? Trends Pharmacol Sci. 15:1994;451-455.
9. 4 receptors in human atrium: facilitation by chronic β-adrenoceptor blockade. Naunyn Schmiedebergs Arch Pharmacol. 349:1994;331-337.
10. 1-adenosine receptor stimulation. Br J Pharmacol. 122:1997;963-969.
11. Bush H.L., Gelband H., Hoffman B.F., Malm J.R. Electrophysiological basis for supraventricular arrhythmias. Arch Surg. 103:1971;620-624.
12. Escande D., Loisance D., Planche C., Coraboeuf E. Age-related changes of action potential plateau shape in isolated human atrial fibers. Am J Physiol. 249:1985;H843-H850.
13. Gelband H., Bush H.L., Rosen M.R., Myerburg R.J., Hoffman B.F. Electrophysiologic properties of isolated preparations of human atrial myocardium. Circ Res. 30:1972;293-300.
14. Singer DH. Automaticity in human cardiac tissue. In: Rosen MR, Janse MJ, Wit AL, editors. Cardiac electrophysiology: a textbook. Mount Kisco, NY: Futura, 1990:247-263.
15. Ten Eick R.E., Singer D.H. Electrophysiological properties of diseased human atrium: Low diastolic potential and altered cellular response to potassium. Circ Res. 44:1979;545-557.
16. Wang Z., Fermini B., Nattel S. Delayed rectifier outward current and repolarization in human atrial myocytes. Circ Res. 73:1993;276-285.
17. + currents in isolated human ventricular myocytes from patients with terminal heart failure. Circ Res. 73:1993;379-385.
18. f, in ventricular myocytes isolated from hypertensive rats. J Physiol (Lond). 481:1994;585-591.
19. Cerbai E., Barbieri M., Li Q., Mugelli A. Ionic basis of action potential prolongation of hypertrophied cardiac myocytes isolated from hypertensive rats of different ages. Cardiovasc Res. 28:1994;1180-1187.
20. f in ventricular myocytes from normotensive and hypertensive rats during aging. Circulation. 94:1996;1674-1681.
21. f, in ventricular myocytes from human failing heart. Circulation. 95:1997;568-571.
22. 2+ current is expressed in hypertrophied adult feline left ventricular myocytes. Circ Res. 73:1993;777-782.
23. + current densities and Kv1.5 expression are reduced in chronic human atrial fibrillation. Circ Res. 80:1997;772-781.
24. Accili E.A., Redaelli G., DiFrancesco D. Differential control of the hyperpolarization-activated current (i(f)) by cAMP gating and phosphatase inhibition in rabbit sino-atrial node myocytes. J Physiol (Lond). 500:1997;643-651.
25. DiFrancesco D., Tortora P. Direct activation of cardiac pacemaker channels by intracellular cyclic AMP. Nature. 351:1991;145-147.
26. f, in human atrial myocytes (Abstract). Circulation. 94:1996;2770.
27. Jacobson SL, Altschuld RA, Hohl H. Muscle cell cultures from human heart. In: Piper HM, editor. Cell culture techniques in heart and vessel research. Springer, Berlin/Heidelberg/New York, 1990:75-98.
28. Pelzmann B., Schaffer P., Mächler H., Rigler B., Koidl B. Adenosine inhibits the L-type calcium current in human atrial myocytes. Naunyn Schmiedberg's Arch Pharmacol. 351:1995;293-297.
29. 4 receptors by chronic beta-blocker treatment. Circulation. 92:1995;2526-2539.
30. World Medical Association Declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. Cardiovasc Res 1997;35:2-3.
31. 4 receptor. Life Sci. 51:1992;583-592.
32. 4 recognition sites in the porcine caudate nucleus by radioligand binding. Neuropharmacology. 33:1994;543-549.
33. 4 agonists: BIMU 1 and BIMU 8. Life Sci. 58:1996;2297-2309.
34. 4 receptor antagonist of the azabicycloalkyl benzimidazolone class: DAU 6285. Naunyn Schmiedebergs Arch Pharmacol. 345:1992;264-269.
35. Vassalle M., Mugelli A. An oscillatory current in sheep cardiac Purkinje fibers. Circ Res. 48:1981;618-631.
36. Hou Z.Y., Lin C.I., Vassalle M., Chiang B.N., Cheng K.K. Role of acetylcholine in induction of repetitive activity in human atrial fibers. Am J Physiol. 256:1989;H74-H84.
37. Wit AL, Rosen MR. Afterdepolarization ant triggered activity. In: Fozzard H, Heber E, Jennings R, editors. The heart and cardiovascular system. New York: Raven Press, 1986:1449-1491.
38. Narayan S.M., Cain M.E., Smith J.M. Atrial fibrillation. Lancet. 350:1997;943-950.